SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031830
Filing Date
2023-11-14
Accepted
2023-11-14 11:31:18
Documents
43
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20230930_10q.htm   iXBRL 10-Q 884362
2 EXHIBIT 3.1 ex_590644.htm EX-3.1 128370
3 EXHIBIT 31.1 ex_565677.htm EX-31.1 16187
4 EXHIBIT 31.2 ex_565678.htm EX-31.2 14589
5 EXHIBIT 32.1 ex_565679.htm EX-32.1 10215
  Complete submission text file 0001437749-23-031830.txt   4450717

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230930.xsd EX-101.SCH 36796
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20230930_cal.xml EX-101.CAL 18412
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230930_def.xml EX-101.DEF 257916
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230930_lab.xml EX-101.LAB 251676
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230930_pre.xml EX-101.PRE 277581
37 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230930_10q_htm.xml XML 618513
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 231402790
SIC: 2834 Pharmaceutical Preparations